NO750031L - - Google Patents

Info

Publication number
NO750031L
NO750031L NO750031A NO750031A NO750031L NO 750031 L NO750031 L NO 750031L NO 750031 A NO750031 A NO 750031A NO 750031 A NO750031 A NO 750031A NO 750031 L NO750031 L NO 750031L
Authority
NO
Norway
Application number
NO750031A
Other languages
Norwegian (no)
Other versions
NO143128B (no
NO143128C (no
Inventor
H Bachmayer
G Schmidt
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of NO750031L publication Critical patent/NO750031L/no
Publication of NO143128B publication Critical patent/NO143128B/no
Publication of NO143128C publication Critical patent/NO143128C/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/145—Orthomyxoviridae, e.g. influenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16211—Influenzavirus B, i.e. influenza B virus
    • C12N2760/16234—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
NO750031A 1974-01-14 1975-01-06 Fremgangsmaate til isolering av hemagglutinin- og neuraminidase-bestanddeler fra et influensavirus NO143128C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH44774A CH589453A5 (fr) 1974-01-14 1974-01-14

Publications (3)

Publication Number Publication Date
NO750031L true NO750031L (fr) 1975-08-11
NO143128B NO143128B (no) 1980-09-15
NO143128C NO143128C (no) 1980-12-29

Family

ID=4187233

Family Applications (1)

Application Number Title Priority Date Filing Date
NO750031A NO143128C (no) 1974-01-14 1975-01-06 Fremgangsmaate til isolering av hemagglutinin- og neuraminidase-bestanddeler fra et influensavirus

Country Status (27)

Country Link
JP (2) JPS58407B2 (fr)
AT (1) AT345449B (fr)
AU (1) AU500250B2 (fr)
BE (1) BE824372A (fr)
CA (1) CA1049406A (fr)
CH (1) CH589453A5 (fr)
CS (1) CS191254B2 (fr)
DD (1) DD116239A5 (fr)
DE (1) DE2500785B2 (fr)
DK (1) DK140003B (fr)
ES (1) ES433759A1 (fr)
FI (1) FI54053C (fr)
FR (1) FR2257305B1 (fr)
GB (1) GB1498261A (fr)
HK (1) HK56380A (fr)
HU (1) HU173920B (fr)
IE (1) IE40794B1 (fr)
IL (1) IL46426A (fr)
MY (1) MY8100204A (fr)
NL (1) NL166622C (fr)
NO (1) NO143128C (fr)
PH (1) PH14458A (fr)
PL (1) PL93689B1 (fr)
SE (1) SE427238B (fr)
SU (1) SU616997A3 (fr)
YU (1) YU41289B (fr)
ZA (1) ZA75259B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2829089A1 (de) * 1977-07-13 1979-02-01 Sandoz Ag Subunit-vakzine
JPH0688911B2 (ja) * 1985-06-06 1994-11-09 国立予防衛生研究所長 インフルエンザワクチン及びその製造方法
TW570803B (en) * 1997-04-09 2004-01-11 Duphar Int Res Influenza vaccine
EP0919243A1 (fr) 1997-11-25 1999-06-02 Duphar International Research B.V Vaccin dont l'adjuvant est constitué de sous-unités B de l'entérotoxine thermolabile (LTB) d'Escherichia coli
DE19938767C2 (de) * 1999-08-16 2002-10-24 Tad Pharma Gmbh Spaltimpfstoffe
CN104474543A (zh) * 2005-11-01 2015-04-01 诺华疫苗和诊断有限两合公司 经由β-丙内酯处理的残留细胞DNA水平降低的细胞衍生病毒疫苗
RU2496519C2 (ru) * 2007-08-28 2013-10-27 Бакстер Интернэшнл Инк. Способ получения препарата, содержащего вирусные антигены, и применение препарата
JP6373376B2 (ja) 2013-11-15 2018-08-15 ノバルティス アーゲー 残留細胞培養不純物の除去

Also Published As

Publication number Publication date
CA1049406A (fr) 1979-02-27
HK56380A (en) 1980-10-16
FR2257305B1 (fr) 1982-03-19
JPS50100224A (fr) 1975-08-08
AU500250B2 (en) 1979-05-17
HU173920B (hu) 1979-09-28
IL46426A0 (en) 1975-04-25
SE427238B (sv) 1983-03-21
PL93689B1 (fr) 1977-06-30
YU5875A (en) 1984-04-30
IL46426A (en) 1978-01-31
JPS58407B2 (ja) 1983-01-06
FR2257305A1 (fr) 1975-08-08
SE7500130L (fr) 1975-07-15
NO143128B (no) 1980-09-15
FI750014A (fr) 1975-07-15
DE2500785A1 (de) 1975-07-31
ATA21475A (de) 1978-01-15
CS191254B2 (en) 1979-06-29
IE40794B1 (en) 1979-08-15
IE40794L (en) 1975-07-14
NO143128C (no) 1980-12-29
ZA75259B (en) 1976-08-25
DK1475A (fr) 1975-09-01
YU41289B (en) 1987-02-28
SU616997A3 (ru) 1978-07-25
NL166622C (nl) 1981-09-15
ES433759A1 (es) 1977-02-16
NL7500301A (nl) 1975-07-16
DD116239A5 (fr) 1975-11-12
CH589453A5 (fr) 1977-07-15
FI54053B (fi) 1978-06-30
DE2500785B2 (de) 1980-01-03
FI54053C (fi) 1978-10-10
NL166622B (nl) 1981-04-15
GB1498261A (en) 1978-01-18
AT345449B (de) 1978-09-11
DE2500785C3 (fr) 1980-09-11
JPS6035326B2 (ja) 1985-08-14
JPS56127319A (en) 1981-10-06
MY8100204A (en) 1981-12-31
PH14458A (en) 1981-07-29
AU7730575A (en) 1976-07-15
BE824372A (fr) 1975-07-14
DK140003C (fr) 1979-10-29
DK140003B (da) 1979-06-05

Similar Documents

Publication Publication Date Title
NO750031L (fr)
AU495920B2 (fr)
JPS50103008A (fr)
AU7138274A (fr)
AU7099174A (fr)
BG20159A1 (fr)
CH1107074A4 (fr)
AU481340A (fr)
BG20729A1 (fr)
AU481580A (fr)
AU482019A (fr)
AU482110A (fr)
AU482332A (fr)
AU481082A (fr)
AU481044A (fr)
AU480580A (fr)
BG19607A1 (fr)
BG19772A1 (fr)
BG19828A1 (fr)
BG19873A1 (fr)
BG19954A1 (fr)
BG19982A1 (fr)
BG20853A1 (fr)
AU480469A (fr)
BG20443A1 (fr)